SLI
1.974,07
PKT
-1,65
PKT
-0,08
%
Werbung
Analysen zu SLI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 12.05.15 | Zurich Insurance Outperform | Credit Suisse Group | |
| 11.05.15 | Swiss Re buy | Deutsche Bank AG | |
| 11.05.15 | UBS buy | Société Générale Group S.A. (SG) | |
| 11.05.15 | UBS buy | Deutsche Bank AG | |
| 11.05.15 | Holcim Neutral | UBS AG | |
| 11.05.15 | Holcim Neutral | UBS AG | |
| 08.05.15 | UBS Neutral | Credit Suisse Group | |
| 08.05.15 | Swiss Re Neutral | UBS AG | |
| 07.05.15 | Zurich Insurance Hold | S&P Capital IQ | |
| 08.05.15 | Zurich Insurance Hold | S&P Capital IQ | |
| 06.05.15 | ABB (Asea Brown Boveri) Equal-Weight | Morgan Stanley | |
| 06.05.15 | UBS overweight | Morgan Stanley | |
| 06.05.15 | UBS Reduce | Kepler Cheuvreux | |
| 06.05.15 | UBS buy | Kepler Cheuvreux | |
| 06.05.15 | UBS buy | Nomura | |
| 06.05.15 | UBS Underperform | BNP PARIBAS | |
| 06.05.15 | UBS overweight | JP Morgan Chase & Co. | |
| 06.05.15 | UBS buy | Deutsche Bank AG | |
| 05.05.15 | UBS kaufen | Independent Research GmbH | |
| 05.05.15 | ABB (Asea Brown Boveri) Halten | Independent Research GmbH | |
| 05.05.15 | Holcim Hold | S&P Capital IQ | |
| 05.05.15 | Holcim buy | S&P Capital IQ | |
| 05.05.15 | UBS Strong Buy | S&P Capital IQ | |
| 05.05.15 | ABB (Asea Brown Boveri) Neutral | Nomura | |
| 05.05.15 | Swiss Re Neutral | Goldman Sachs Group Inc. | |
| 05.05.15 | UBS Hold | Commerzbank AG | |
| 05.05.15 | Zurich Insurance overweight | Barclays Capital | |
| 05.05.15 | Swiss Re Equal weight | Barclays Capital | |
| 30.04.15 | Swiss Re kaufen | DZ-Bank AG | |
| 30.04.15 | UBS overweight | Morgan Stanley | |
| 30.04.15 | ABB (Asea Brown Boveri) Sell | Goldman Sachs Group Inc. | |
| 30.04.15 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
| 30.04.15 | ABB (Asea Brown Boveri) Neutral | UBS AG | |
| 29.04.15 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
| 29.04.15 | Roche buy | Merrill Lynch & Co., Inc. | |
| 29.04.15 | ABB (Asea Brown Boveri) buy | S&P Capital IQ | |
| 29.04.15 | Roche overweight | JP Morgan Chase & Co. | |
| 29.04.15 | Novartis buy | Citigroup Corp. | |
| 29.04.15 | Roche Neutral | Citigroup Corp. | |
| 29.04.15 | Holcim buy | Jefferies & Company Inc. |